• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis

    2017-09-04 07:27:38JohnSoltysQinWangYangMaoDraayer

    John Soltys, Qin Wang, Yang Mao-Draayer,

    1 Present Address: University of Colorado Medical Scientist Training Program (MSTP), Aurora, CO, USA

    2 Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA

    Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis

    John Soltys1, Qin Wang2, Yang Mao-Draayer2,*

    1 Present Address: University of Colorado Medical Scientist Training Program (MSTP), Aurora, CO, USA

    2 Department of Neurology, University of Michigan Medical School, Ann Arbor, MI, USA

    How to cite this article:Soltys J, Wang Q, Mao-Draayer Y (2017) Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis. Neural Regen Res 12(8):1352-1356.

    Benign multiple sclerosis is a retrospective diagnosis based primarily on a lack of motor symptom progression. Recent fi ndings that suggest patients with benign multiple sclerosis experience non-motor symptoms highlight the need for a more prospective means to diagnose benign multiple sclerosis early in order to help direct patient care. In this study, we present optical coherence tomography and T cell neurotrophin gene analysis fi ndings in a small number of patients with benign multiple sclerosis. Our results demonstrated that retinal nerve fi ber layer was mildly thinned, and T cells had a distinct gene expression prof i le that included upregulation of interleukin 10 and leukemia inhibitory factor, downregulation of interleukin 6 and neurotensin high af fi nity receptor 1 (a novel neurotrophin receptor).ese fi ndings add evidence for further investigation into optical coherence tomography and mRNA prof i ling in larger cohorts as a potential means to diagnose benign multiple sclerosis in a more prospective manner.

    neurotensin high af finity receptor 1; benign multiple sclerosis; optical coherence tomography; interleukin 10; T cell; leukemia inhibitory factor; optic neuritis; neural regeneration

    Introduction

    Diagnosis of benign multiple sclerosis (BMS) is a clinical challenge. BMS diagnosis is primarily retrospective and is heavily weighted towards motor progression, and in particular depends on a condition that an Expanded Disability Status Scale (EDSS) ≤ 3 aer at least 10 or 15 years of disease onset without disease modifying therapy (DMT) (Ramsaransing and De Keyser, 2006; Zimmermann et al., 2013). However, recent reports have demonstrated that BMS patients experience a range of non-motor symptoms including cognitive dysfunction, pain and depression (Hviid et al., 2011; Sayao et al., 2011; Correale et al., 2012).us, identifying a prospective means to diagnose BMS has signif i cant implications for treatment and patient management as these symptoms can negatively impact quality of life. Investigating the plausibility of using newer technologies to diagnose BMS represents one approach to achieve this goal.

    In this study, we reported a small case series of BMS patients with their clinical course, magnetic resonance imaging (MRI), optical coherence tomography (OCT) and T cell gene expression analysis in our study. We provide evidence that OCT and mRNA prof i ling represent plausible technologies to pursue in larger cohorts that aim to further dif f erentiate BMS from progressive MS.

    Subjects and Methods

    Subjects

    The study was conducted in compliance with the principles of theDeclaration of Helsinki. The University of Vermont institutional review board reviewed and approved the study protocol (approval No. CHRMS09-092). All patients provided written informed consent. Three patients with BMS were recruited from the Multiple Sclerosis Center at the University of Vermont.e diagnosis of BMS was based on an Expanded Disability Status Scale (EDSS) ≤ 3 aer at least 10 or 15 years of disease onset (Ramsaransing and De Keyser, 2006). Since disease modifying therapy (DMT) use/non-use was signif i cantly associated with maintaining a benign disease state (Zivadinov et al., 2016) and also can modulate the loss of retinal nerve fi ber layer (RNFL; Button et al., 2017), we focused on patients with BMS who maintain a non-progressive benign status without prior treatment with DMT.

    OCT scanning

    T cell isolation and culture

    T cell isolation, activation and culture were performed according to a previous study by Soltys et al. (2014). Briefly, peripheral blood mononuclear cells (PBMCs) were obtained from the whole blood by standard Ficoll gradient centrifugation. T cells were isolated from this cell population using a Pan T cell isolation kit (Miltenyi Biotech Inc. Auburn, CA, USA) according to manufacturer protocol. In brief, non-T cells were bound with biotin conjugated antibodies against CD14, CD16, CD19, CD36, CD56, CD123, and glycophorin A.ese cells were captured with anti-biotin microbeads and magnetically depleted by passing the cells through the column (negative selection) to produce a highly pure (90–97%) population of T cells. Cell purity was conf i rmed by fl ow cytometry using human T cell receptor (TCR) staining (FITC conjugated mouse anti-human TCR standard FiPharmingen). Isolated T cells were cultured in T cell complete media (RPMI media, 10% fetal calf serum, 2.5 g/L glucose, 2 nM glutamine, 10 μg/ mL folate, 1 mM pyruvate, 50 μM 2-mercaptoethanol). Cultures were stimulated with human anti-CD3 and anti-CD28 monoclonal antibodies (5 μg/106cells) and cultured for 48 hours, at 37°C and 5% CO2. Prior to RNA extraction, all cells were collectedviacentrifugation and the supernatants immediately frozen at –80°C for protein analysis.

    mRNA isolation

    Figure 1 MRI findings in the brain of three patients with benign multiple sclerosis.

    mRNA isolation and profiling were described according to previous reports (Soltys et al., 2014; Wang et al., 2015). In brief, RNA was extracted from T cells using the RNeasy RNA Extraction Kit (Qiagen). RNA quality control and integrity were assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies Inc. Santa Clara, CA, USA). Absence of genomic DNA contamination was conf i rmed by RT-qPCR. RNA samples were reverse transcribed to cDNA using the SuperArray RT2 First Strand Kit (Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA), according to manufacturer protocol.

    Gene array and real time-quantitative polymerase chain reaction (RT-qPCR)

    RNA (200 ng) was reversed transcribed to cDNA using the SuperArray RT-2 First-Strand cDNA synthesis kit (SA Biosciences, QIAGEN Inc., Germantown, MD, USA). cDNA samples were run on the SuperArray plate “Neurotrophins and Receptors” (PAHS-31A, SABiosciences, QIAGEN Inc., Germantown, MD, USA) using Applied Biosystems 7900HT (Applied Biosys-tems Inc., Foster City, CA, USA), to analyze 84 neurotrophic factors and receptors, and 5 housekeeping genes.

    Figure 2 mRNA gene prof i ling of T cells isolated from each patient with benign multiple sclerosis.

    Table 1 Patient demographics and OCT data

    Results were quanti fi ed using the 2-ample method and expressed as a fold di ff erence with respect to the healthy control group (n= 5, 4 females and 1 male, aged 33 ± 12 years, recruited from the Multiple Sclerosis Center at the University of Vermont, USA). For all analysis, a Ct cuto ff of > 35 was used to define a gene as undetectable. All prepared graphs and statistical analyses were run using GraphPad?Prism software (GraphPad Software Inc.). Analysis of variance and Benjamini-Hochberg post-test were used to determine signi fi cance.e candidate genes were further con fi rmed by RT-qPCR using Applied Biosystems 7500 (ermo Scienti fi c, Grand Island, NY, USA). RT-qPCR method was described in previous studies (Soltys et al., 2014; Wang et al., 2015). Amplifi cation consisted of 40 cycles of 95°C for 15 seconds and 60°C for 1 minute with approximately 15 ng/μL cDNA. TaqMan Master Mix and speci fi c primer pairs for leukemia inhibitory factor (LIF) and interleukin-10 (IL-10) were purchased from Applied Biosystems (assay on demands primers) (Applied Biosystems Inc., Foster City, CA, USA). RT-qPCR was performed using Taqman?Master Mix (Applied Biosystems Inc.,) and applied Biosystems 7500 Fast Software (Applied Biosystems Inc.).

    Statistical analysis

    SuperArray statistical analysis was done with the PCR Data Array Web Portal provided by SABiosciences. Pairwise comparisons between groups of experimental replicates were performed. A level ofP< 0.05 was considered statistically significant. Analysis of variance and Benjamini-Hochberg post-test were used to determine signif i cance. Data were exported and all prepared graphs and statistical analyses were run using GraphPad?Prism 6 soware (GraphPad Soware Inc., San Diego, CA, USA).

    Results

    Patient #1

    Patient #2

    Patient #3

    We performed OCT on each patient. Patient age, disease duration, EDSS at the time of OCT, and blood drawing (described below) are summarized in Table 1. Of note, in these patients, the EDSS was only 1.0–1.5 despite disease duration ranging from 17 to 32 years. The mean RNFL thickness was mildly decreased in the optic neuritis affected eyes while healthy non-optic neuritis eyes had relatively normal RNFL (Table 1).

    We isolated T cells from peripheral blood samples of each patient and healthy control. T cell mRNA was extracted aer 48 hours of culture with anti-CD3 and anti-CD28 antibodies. A SuperArray gene analysis using a “Neurotrophins and Receptors” plate (PAHS-31A, SABiosciences) was done to screen for potential genes of interests (Figure 2A). The fold changes were then confirmed using RT-qPCR against healthy controls (Figure 2C) (detailed methods see previous publication in Soltys et al., 2014). The mRNA levels of IL-10 and LIF were signif i cantly increased in T cells of patients with BMS (Figure 2A).

    Discussion

    Despite long-standing disease in our patients, there is minimal deterioration in healthy eyes. One hypothesis may be that a more benign clinical course can be predicted by a slower rate of RNFL deterioration in healthy eyes, compared to more aggressive forms of MS (Syc et al., 2012; Zimmermann et al., 2013; Galetta et al., 2015; Martinez-Lapiscina et al., 2016). Our data in Table 1 support the hypothesis that the non-ON eyes have normal values in BMS patients.

    We therefore attempted to identify molecular signatures of BMS. Recent evidence suggests that T cell-mediated inf l ammation may be beneficial and neuroprotective via altered neurotrophin production in MS (Correale and Villa, 2004; Soltys et al., 2014; Wang and Mao-Draayer, 2015; Johnson et al., 2016). To the best of our knowledge, the distinct neurotrophic factor/cytokine contributions from specif i c cell populations have not been studied in BMS. In this study, we isolated T cells, the key mediators of MS immunopathogenesis, from peripheral blood samples of three patients with benign MS. A SuperArray gene analysis was performed to screen for neurotrophin and neurtrophin receptor related genes. BMS patients demonstrate signif i cantly elevated mRNA levels of IL-10 and LIF in T cells, which was consistent with previous studies showing that mRNA expression of IL-10 and LIF in peripheral blood mononuclear cells was elevated in patients with stable MS than in patients with active MS (Byskosh and Reder, 1996; Krakauer et al., 2008; Metcalfe et al., 2015). Furthermore, the mRNA levels of IL-6, novel neurotrophin receptor, and neurotensin high af finity receptor 1 were decreased in patients with BMS than in healthy controls.is supports our previous report that interferon-β treatment can induce the expression of anti-inflammatory cytokines and upregulate neurotensin high affinity receptor 1 in T cells (Soltys et al., 2014; Wang and Mao-Draayer, 2015). IL-6, secreted by T cells and macrophages during infection and trauma, acts mostly as pro-inflammatory cytokine in MS (Melamed et al., 2015). IL-6 together with transforming growth factor-β mediates Th17/Treg balances by promoting17 development and accelerating FoxP3 degradation (Kimura and Kishimoto, 2010).erefore, decreased IL-6 in T cells from the BMS patients could be another surrogate marker for BMS. Although we cannot generalize the potential roles of these specif i c factors given our small sample size, our fi ndings show that a more benign clinical course leads to a more distinct neurotrophin gene expression profile which in combination with OCT measurement could serve as biomarkers to aid the diagnosis of BMS. Further investigations with larger cohorts over time will allow us to extend our observation.

    This study provides evidence that OCT and T cell neurotrophin mRNA gene expression prof i ling represents plausible technologies to help differentiate BMS from progressive MS. However, in this study, only three patients with benign MS were recruited.erefore, OCT studies involving a larger cohort of patients with gene expression prof i le are needed to confirm our findings. Given the diverse presentations of clinical courses in BMS patients, it is likely that neither approach alone will suffice. A collaborative approach that correlates routine imaging fi ndings (MRI, OCT) to blood and CSF biomarkers, EDSS and non-motor symptoms may best capture the range of benign clinical courses in a more prospective manner.

    Acknowledgments:We thank the Center of Biomedical Research Excellence (COBRE) at the University of Vermont for their support and equipment access, and the UVM Cancer Center DNA Analysis Facility for their assistance with our SuperArray assays. We thank our ophthalmology technician Jef f rey Abell for performing optical coherence tomography and Patricia Shea for helping with the case review.

    Author contributions:YMD designed this study, recruited patients and wrote the paper. JS and QW were responsible for data collection and also participated in the writing of this paper. All authors approved the fi nal version of this paper.

    Conf l icts of interest:None declared.

    Research ethics:

    Declaration of patient consent:The authors certify that they have obtained all appropriate patient consent forms. In the form, the patients have given their consent for their images and other clinical information to be reported in the journal.e patients understand that their names and initials will not be published and due ef f orts will be made to conceal their identity, but anonymity cannot be guaranteed.

    Data sharing statement:

    Plagiarism check:Checked twice by ienticate.

    Peer review:Externally peer reviewed.

    Open access statement:

    Open peer review report:

    Reviewer: Chunjian Huang, National Jewish Health, USA.

    Additional fi le: Open peer review report 1.

    Balk L, Tewarie P, Killestein J, Polman C, Uitdehaag B, Petzold A (2014) Disease course heterogeneity and OCT in multiple sclerosis. Mult Scler 20:1198-1206.

    Button J, Al-Louzi O, Lang A, Bhargava P, Newsome SD, Frohman T, Balcer LJ, Frohman EM, Prince J, Calabresi PA, Saidha S (2017) Disease-modifying therapies modulate retinal atrophy in multiple sclerosis: a retrospective study. Neurology 88:525-532.

    Byskosh PV, Reder AT (1996) Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler 1:262-269.

    Cettomai D, Pulicken M, Gordon-Lipkin E, Salter A, Frohman TC, Conger A, Zhang X, Cutter G, Balcer LJ, Frohman EM, Calabresi PA (2008) Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol 65:1218-1222.

    Correale J, Villa A (2004)e neuroprotective role of inf l ammation in nervous system injuries. J Neurol 251:1304-1316.

    Correale J, Peirano I, Romano L (2012) Benign multiple sclerosis: a new def i nition of this entity is needed. Mult Scler 18:210-218.

    Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Martinez-Lapiscina EH, Lagreze WA, Schuman JS, Villoslada P, Calabresi P, Balcer L, Petzold A, Green AJ, Paul F, Brandt AU, Albrecht P; IMSVISUAL consortium (2016) The APOSTEL recommendations for reporting quantitative optical coherence tomography studies. Neurology 86:2303-2309.

    D?rr J, Wernecke KD, Bock M, Gaede G, Wuerfel JT, Pfueller CF, Bellmann-Strobl J, Freing A, Brandt AU, Friedemann P (2011) Association of retinal and macular damage with brain atrophy in multiple sclerosis. PLoS One 6:e18132.

    Galetta SL, Villoslada P, Levin N, Shindler K, Ishikawa H, Parr E, Cadavid D, Balcer LJ ( 2015) Acute optic neuritis: unmet clinical needs and model for new therapies. Neurol Neuroimmunol Neuroinf l amm 2:e135.

    Huang-Link YM, Fredrikson M, Link H (2015) Benign multiple sclerosis is associated with reduced thinning of the retinal nerve fi ber and ganglion cell layers in non-optic-neuritis eyes. J Clin Neurol 11:241-247.

    Hviid LE, Healy BC, Rintell DJ, Chitnis T, Weiner HL, Glanz BI (2011) Patient reported outcomes in benign multiple sclerosis. Mult Scler 17:876-884.

    Johnson MC, Pierson ER, Spieker AJ, Nielsen AS, Posso S, Kita M, Buckner JH, Goverman JM (2016) Distinct T cell signatures def i ne subsets of patients with multiple sclerosis. Neurol Neuroimmunol Neuroinf l amm 3:e278.

    Kimura A, Kishimoto T (2010) IL-6: regulator of Treg/17 balance. Eur J Immunol 40:1830-1835.

    Krakauer M, Sorensen P, Khademi M, Olsson T, Sellebjerg F (2008) Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult Scler 14:622-630.

    Lange AP, Zhu F, Sayao AL, Sadjadi R, Alkabie S, Traboulsee AL, Costello F, Tremlett H (2013) Retinal nerve fi ber layer thickness in benign multiple sclerosis. Mult Scler 19:1275-1281.

    Martinez-Lapiscina EH, Arnow S, Wilson JA, Saidha S, Preiningerova JL, Oberwahrenbrock T, Brandt AU, Pablo LE, Guerrieri S, Gonzalez I, Outteryck O, Mueller AK, Albrecht P, Chan W, Lukas S, Balk LJ, Fraser C, Frederiksen JL, Resto J, Frohman T, et al. (2016) Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study. Lancet Neurol 15:574-584.

    Melamed E, Levy M, Waters PJ, Sato DK, Bennett JL, John GR, Hooper DC, Saiz A, Bar-Or A, Kim HJ, Pandit L, Leite MI, Asgari N, Kissani N, Hintzen R, Marignier R, Jarius S, Marcelletti J, Smith TJ, Yeaman MR, et al. (2015) Update on biomarkers in neuromyelitis optica. Neurol Neuroimmunol Neuroinf l amm 2:e134.

    Metcalfe SM, Strom TB, Williams A, Fahmy TM (2015) Multiple sclerosis and the LIF/IL-6 axis: use of nanotechnology to harness the tolerogenic and reparative properties of LIF. Nanobiomedicine 2:5.

    Oberwahrenbrock T, Schippling S, Ringelstein M, Kauold F, Zimmermann H, Keser N, Young KL, Harmel J, Hartung HP, Martin R, Paul F, Aktas O, Brandt AU (2012) Retinal damage in multiple sclerosis disease subtypes measured by high-resolution optical coherence tomography. Mult Scler Int 2012:530305.

    Patella VM (2010) Stratus OCT: Establishment of normative reference values for retinal nerve fi ber layer thickness measurements. Carl Zeiss Meditec Web site. Available at: http://www.meditec.zeiss.de/88256DE3007B-916B/0/55B63359D850E15D882575E7000AA4AE/$file/stratusoct5_ en.pdf. Accessed February 27, 2010.

    Ramsaransing GS, De Keyser J (2006) Benign course in multiple sclerosis: a review. Acta Neurol Scand 113:359-369.

    Saidha S, Syc SB, Durbin MK, Eckstein C, Oakley JD, Meyer SA, Conger A, Frohman TC, Newsome S, Ratchford JN, Frohman EM, Calabresi PA (2011) Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fi ber layer thickness. Mult Scler 17:1449-1463.

    Sayao AL, Bueno AM, Devonshire V, Tremlett H (2011)e psychosocial and cognitive impact of longstanding ‘benign’ multiple sclerosis. Mult Scler 17:1375-1383

    Sergott RC, Bennett JL, Rieckmann P, Montalban X, Mikol D, Freudensprung U, Plitz T, van Beek J; ATON Trial Group (2015) ATON: results from a Phase II randomized trial of the B-cell-targeting agent atacicept in patients with optic neuritis. J Neurol Sci 351(1-2):174-178.

    Soltys J, Knight J, Scharf E, Pitt D, Mao-Draayer Y (2014) IFN-β alters neurotrophic factor expression in T cells isolated from multiple sclerosis patients - implication of novel neurotensin/NTSR1 pathway in neuroprotection. Am J Transl Res 6:312-319.

    Syc SB, Saidha S, Newsome SD, Ratchford JN, Levy M, Ford E, Crainiceanu CM, Durbin MK, Oakley JD, Meyer SA, Frohman EM, Calabresi PA (2012) Optical coherence tomography segmentation reveals ganglion cell layer pathology aer optic neuritis. Brain 135(Pt 2):521-533.

    Wang Q, Chuikov S, Taitano S, Wu Q, Rastogi A, Tuck SJ, Corey JM, Lundy SK, and Mao-Draayer Y (2015) Dimethyl fumarate protects neural stem/progenitor cells and neurons from oxidative damage through Nrf2-ERK1/2 MAPK pathway. Int J Mol Sci 16:13885-13907.

    Wang Q, Mao-Draayer Y (2015) Neuroprotective ef f ect of IFN-β treatment is involved in neurotrophic factors and novel NT/NTSR1 pathway. Neural Regen Res 10:1932-1933.

    Zimmermann H, Freing A, Kaufhold F, Gaede G, Bohn E, Bock M, Oberwahrenbrock T, Young KL, D?rr J, Wuerfel JT, Schippling S, Paul F, Brandt AU (2013) Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations. Mult Scler 19:443-150.

    Zivadinov R, Cookfair DL, Krupp L, Miller AE, Lava N, Coyle PK, Goodman AD, Jubelt B, Lenihan M, Herbert J, Gottesman M, Snyder DH, Apatof f BR, Teter BE, Perel AB, Munschauer F, Weinstock-Guttman B (2016) Factors associated with benign multiple sclerosis in the New York State MS Consortium (NYSMSC). BMC Neurol 16:102.

    Copyedited by Li CH, Song LP, Zhao M

    *< class="emphasis_italic">Correspondence to: Yang Mao-Draayer, M.D., Ph.D., maodraay@umich.edu.

    Yang Mao-Draayer, M.D., Ph.D., maodraay@umich.edu.

    orcid: 0000-0001-6248-3480 (Yang Mao-Draayer)

    10.4103/1673-5374.213558

    Accepted: 2017-07-22

    熟女人妻精品中文字幕| 国产精品一区二区三区四区免费观看| 中文天堂在线官网| 五月玫瑰六月丁香| 美女cb高潮喷水在线观看| 如何舔出高潮| 伊人久久精品亚洲午夜| 免费高清在线观看视频在线观看| 大码成人一级视频| 亚洲综合精品二区| 欧美97在线视频| h日本视频在线播放| 深夜a级毛片| 久久久精品94久久精品| 人妻少妇偷人精品九色| h视频一区二区三区| 亚洲电影在线观看av| 国产一区二区在线观看日韩| 日日摸夜夜添夜夜爱| 欧美丝袜亚洲另类| 不卡视频在线观看欧美| 黄片无遮挡物在线观看| 日本爱情动作片www.在线观看| 韩国av在线不卡| 在线观看免费视频网站a站| 欧美三级亚洲精品| 又粗又硬又长又爽又黄的视频| 人妻人人澡人人爽人人| 国产日韩欧美亚洲二区| 午夜福利在线观看免费完整高清在| 亚洲怡红院男人天堂| 国精品久久久久久国模美| 国产亚洲一区二区精品| 国产成人freesex在线| 国产极品天堂在线| 人人妻人人添人人爽欧美一区卜| 中文字幕制服av| 亚洲久久久国产精品| 欧美亚洲 丝袜 人妻 在线| 午夜久久久在线观看| 热99国产精品久久久久久7| 中文字幕人妻熟人妻熟丝袜美| 久久久国产精品麻豆| 3wmmmm亚洲av在线观看| 18禁在线无遮挡免费观看视频| 中文字幕制服av| 岛国毛片在线播放| 九九久久精品国产亚洲av麻豆| 日日摸夜夜添夜夜爱| 午夜精品国产一区二区电影| 欧美最新免费一区二区三区| 亚洲av成人精品一二三区| 国产成人免费无遮挡视频| 久热久热在线精品观看| 亚洲av二区三区四区| 又大又黄又爽视频免费| 国语对白做爰xxxⅹ性视频网站| 乱人伦中国视频| 亚洲国产精品999| 女人久久www免费人成看片| 两个人免费观看高清视频 | 你懂的网址亚洲精品在线观看| 国产男女超爽视频在线观看| 交换朋友夫妻互换小说| 国产精品成人在线| 精品一区二区免费观看| 日韩av免费高清视频| 成人亚洲欧美一区二区av| 美女脱内裤让男人舔精品视频| 亚洲精品乱码久久久久久按摩| 五月伊人婷婷丁香| 草草在线视频免费看| 久久精品久久精品一区二区三区| 97在线人人人人妻| 亚洲国产精品一区二区三区在线| 一级片'在线观看视频| 2021少妇久久久久久久久久久| 又黄又爽又刺激的免费视频.| 国产精品久久久久久久电影| √禁漫天堂资源中文www| 亚洲国产精品成人久久小说| 18+在线观看网站| 日产精品乱码卡一卡2卡三| 亚洲精品国产色婷婷电影| 国产乱来视频区| 中文资源天堂在线| 日韩伦理黄色片| 国产免费一区二区三区四区乱码| 亚洲三级黄色毛片| 国产精品福利在线免费观看| 国产免费视频播放在线视频| 97在线人人人人妻| 91午夜精品亚洲一区二区三区| av一本久久久久| 日韩一区二区三区影片| 伦理电影大哥的女人| 亚洲美女视频黄频| 国产片特级美女逼逼视频| 在线观看免费视频网站a站| 午夜日本视频在线| 久久 成人 亚洲| 免费黄网站久久成人精品| 人人妻人人澡人人爽人人夜夜| 丰满人妻一区二区三区视频av| 国产亚洲精品久久久com| 久久国产精品男人的天堂亚洲 | 大陆偷拍与自拍| 桃花免费在线播放| 亚洲国产色片| 欧美老熟妇乱子伦牲交| 搡女人真爽免费视频火全软件| 一区二区三区免费毛片| 中文字幕久久专区| 国产精品无大码| 在线观看免费高清a一片| 亚洲精品一区蜜桃| 交换朋友夫妻互换小说| 免费观看性生交大片5| 中文字幕免费在线视频6| av天堂中文字幕网| 丰满乱子伦码专区| 妹子高潮喷水视频| 在线天堂最新版资源| 大码成人一级视频| 如何舔出高潮| 日韩欧美 国产精品| av一本久久久久| 晚上一个人看的免费电影| 久久久国产精品麻豆| 日韩中文字幕视频在线看片| 国产精品国产三级国产专区5o| 欧美人与善性xxx| 免费播放大片免费观看视频在线观看| 人妻人人澡人人爽人人| 久久这里有精品视频免费| 国产精品成人在线| 亚洲欧美清纯卡通| kizo精华| 精品久久久久久电影网| 亚洲精品第二区| 99国产精品免费福利视频| 免费播放大片免费观看视频在线观看| 精品人妻熟女av久视频| 国产伦在线观看视频一区| 看非洲黑人一级黄片| 丰满少妇做爰视频| 青春草视频在线免费观看| 亚洲精品日韩在线中文字幕| 人人妻人人添人人爽欧美一区卜| 免费少妇av软件| 男女啪啪激烈高潮av片| 天美传媒精品一区二区| 99九九在线精品视频 | 搡老乐熟女国产| 一边亲一边摸免费视频| 精品久久国产蜜桃| 免费av中文字幕在线| 亚洲第一区二区三区不卡| 国产精品国产三级专区第一集| 国产 一区精品| 一本—道久久a久久精品蜜桃钙片| 天美传媒精品一区二区| 久久午夜福利片| 乱人伦中国视频| 熟女电影av网| 午夜福利在线观看免费完整高清在| 亚洲激情五月婷婷啪啪| 亚州av有码| 国产免费视频播放在线视频| 妹子高潮喷水视频| av视频免费观看在线观看| 插逼视频在线观看| 国产一区二区在线观看日韩| 国产视频首页在线观看| 热99国产精品久久久久久7| 久久精品国产鲁丝片午夜精品| 中文字幕久久专区| 一级毛片黄色毛片免费观看视频| av福利片在线| 18禁在线播放成人免费| 午夜老司机福利剧场| 精品视频人人做人人爽| 只有这里有精品99| 99九九在线精品视频 | 丰满迷人的少妇在线观看| 天堂俺去俺来也www色官网| 成年女人在线观看亚洲视频| 青青草视频在线视频观看| 免费观看的影片在线观看| 人妻少妇偷人精品九色| 久久国产精品男人的天堂亚洲 | 美女大奶头黄色视频| 精品一区在线观看国产| 国模一区二区三区四区视频| 成人二区视频| 国产又色又爽无遮挡免| 免费高清在线观看视频在线观看| 国产高清国产精品国产三级| 中文字幕免费在线视频6| 人妻夜夜爽99麻豆av| 人人澡人人妻人| 高清在线视频一区二区三区| 亚洲精品视频女| 91久久精品国产一区二区成人| 国产淫语在线视频| 亚洲熟女精品中文字幕| 亚洲精品国产av成人精品| 国产精品人妻久久久久久| www.色视频.com| 麻豆乱淫一区二区| 欧美最新免费一区二区三区| 亚洲精品国产色婷婷电影| 精品亚洲乱码少妇综合久久| 国产黄色免费在线视频| 午夜91福利影院| 日韩成人伦理影院| 一本—道久久a久久精品蜜桃钙片| 丰满饥渴人妻一区二区三| 美女脱内裤让男人舔精品视频| 亚洲国产精品一区三区| 十八禁高潮呻吟视频 | 亚洲精品一区蜜桃| 午夜日本视频在线| 一区二区三区乱码不卡18| 亚洲精华国产精华液的使用体验| 国产精品秋霞免费鲁丝片| 在线免费观看不下载黄p国产| 成人亚洲欧美一区二区av| 在线观看国产h片| 十八禁高潮呻吟视频 | av在线app专区| freevideosex欧美| 夜夜骑夜夜射夜夜干| 在线精品无人区一区二区三| 自拍欧美九色日韩亚洲蝌蚪91 | 久久久久视频综合| 免费看av在线观看网站| 欧美xxⅹ黑人| 中文字幕av电影在线播放| 秋霞伦理黄片| 少妇人妻 视频| 亚洲人与动物交配视频| 亚洲av二区三区四区| 久久影院123| 在线观看人妻少妇| 亚洲熟女精品中文字幕| 下体分泌物呈黄色| 亚洲中文av在线| 免费av中文字幕在线| av黄色大香蕉| 国产精品成人在线| 日韩亚洲欧美综合| 成年人免费黄色播放视频 | 国产亚洲av片在线观看秒播厂| 亚洲精品,欧美精品| 国产精品嫩草影院av在线观看| 不卡视频在线观看欧美| 欧美国产精品一级二级三级 | 我要看日韩黄色一级片| 又黄又爽又刺激的免费视频.| 日本午夜av视频| 亚洲国产精品成人久久小说| 夫妻性生交免费视频一级片| 美女xxoo啪啪120秒动态图| 亚洲av成人精品一区久久| 精华霜和精华液先用哪个| 国产 精品1| 国产av码专区亚洲av| 国产综合精华液| 男人添女人高潮全过程视频| 亚洲美女视频黄频| 超碰97精品在线观看| 纵有疾风起免费观看全集完整版| 国产精品久久久久久av不卡| 在线播放无遮挡| 日韩中文字幕视频在线看片| 内地一区二区视频在线| freevideosex欧美| 亚洲精品日本国产第一区| 久久久国产精品麻豆| 免费大片18禁| 大又大粗又爽又黄少妇毛片口| 日韩不卡一区二区三区视频在线| 性色av一级| 永久免费av网站大全| 亚洲高清免费不卡视频| 人妻一区二区av| 97在线视频观看| 在线观看人妻少妇| 最新中文字幕久久久久| 热re99久久精品国产66热6| 欧美精品人与动牲交sv欧美| 午夜91福利影院| 欧美激情极品国产一区二区三区 | 欧美精品国产亚洲| 高清毛片免费看| 国产精品福利在线免费观看| 亚洲欧美一区二区三区国产| 欧美xxⅹ黑人| 国模一区二区三区四区视频| 久久鲁丝午夜福利片| 青春草亚洲视频在线观看| 日韩视频在线欧美| 一级毛片 在线播放| 久久久久久人妻| 国产精品成人在线| 少妇 在线观看| 午夜福利在线观看免费完整高清在| 热re99久久国产66热| 不卡视频在线观看欧美| 成人18禁高潮啪啪吃奶动态图 | 国产在线免费精品| 在线观看国产h片| 国产伦精品一区二区三区四那| av又黄又爽大尺度在线免费看| 又爽又黄a免费视频| 五月伊人婷婷丁香| 亚洲成人一二三区av| 男女边摸边吃奶| 亚洲国产精品成人久久小说| 天堂中文最新版在线下载| 男男h啪啪无遮挡| 久久久久久久久久成人| 欧美少妇被猛烈插入视频| 一级爰片在线观看| 色吧在线观看| 亚洲精品乱码久久久v下载方式| 精华霜和精华液先用哪个| 在线观看www视频免费| 天天躁夜夜躁狠狠久久av| 欧美 亚洲 国产 日韩一| 国产精品一区二区在线观看99| 黄色怎么调成土黄色| 国产成人午夜福利电影在线观看| 国产亚洲午夜精品一区二区久久| 亚洲三级黄色毛片| 精品午夜福利在线看| 国产无遮挡羞羞视频在线观看| 黄色日韩在线| 欧美另类一区| 乱系列少妇在线播放| 80岁老熟妇乱子伦牲交| 精华霜和精华液先用哪个| 啦啦啦视频在线资源免费观看| 国产亚洲欧美精品永久| 国产老妇伦熟女老妇高清| a级片在线免费高清观看视频| 久久久久久久久久成人| 国产高清不卡午夜福利| 精品视频人人做人人爽| freevideosex欧美| 亚洲成人手机| 亚洲av成人精品一区久久| 日韩av不卡免费在线播放| 青春草亚洲视频在线观看| 久久精品国产鲁丝片午夜精品| av网站免费在线观看视频| 亚洲自偷自拍三级| 丝袜脚勾引网站| 亚洲第一av免费看| 精品国产乱码久久久久久小说| 91久久精品国产一区二区成人| 亚洲三级黄色毛片| 一区在线观看完整版| 亚洲精品国产av成人精品| 久久久a久久爽久久v久久| 欧美亚洲 丝袜 人妻 在线| 一本大道久久a久久精品| 精品国产一区二区三区久久久樱花| 国产免费一区二区三区四区乱码| 久久女婷五月综合色啪小说| 亚洲高清免费不卡视频| 国产精品一区二区在线观看99| 99久久综合免费| 看十八女毛片水多多多| 美女内射精品一级片tv| 亚洲av二区三区四区| 精品国产国语对白av| 亚洲成人av在线免费| 性色avwww在线观看| 色94色欧美一区二区| 王馨瑶露胸无遮挡在线观看| 最近中文字幕2019免费版| 一区二区三区乱码不卡18| 插逼视频在线观看| av不卡在线播放| 日本-黄色视频高清免费观看| 亚洲av免费高清在线观看| 欧美xxⅹ黑人| 亚洲欧美中文字幕日韩二区| 久久久亚洲精品成人影院| 最近2019中文字幕mv第一页| 婷婷色麻豆天堂久久| 建设人人有责人人尽责人人享有的| 这个男人来自地球电影免费观看 | 欧美成人午夜免费资源| 亚洲伊人久久精品综合| 国产亚洲av片在线观看秒播厂| 一本—道久久a久久精品蜜桃钙片| 亚洲国产毛片av蜜桃av| 国产国拍精品亚洲av在线观看| 男女无遮挡免费网站观看| 一边亲一边摸免费视频| 少妇的逼水好多| 欧美性感艳星| 欧美日本中文国产一区发布| 啦啦啦中文免费视频观看日本| 国产欧美亚洲国产| 久久国产亚洲av麻豆专区| 国产白丝娇喘喷水9色精品| 六月丁香七月| 成人亚洲欧美一区二区av| 国产精品久久久久成人av| 亚洲电影在线观看av| 男人爽女人下面视频在线观看| 天天操日日干夜夜撸| 国产成人aa在线观看| 亚洲真实伦在线观看| 嘟嘟电影网在线观看| 国产熟女午夜一区二区三区 | 成人亚洲欧美一区二区av| 婷婷色综合www| 永久网站在线| 国产精品99久久99久久久不卡 | 色视频在线一区二区三区| 国产成人精品福利久久| 亚洲高清免费不卡视频| 免费观看在线日韩| 五月天丁香电影| 美女大奶头黄色视频| 国产乱来视频区| 观看av在线不卡| 久久精品国产鲁丝片午夜精品| 日韩三级伦理在线观看| 久久狼人影院| 成人漫画全彩无遮挡| 九草在线视频观看| 亚洲va在线va天堂va国产| 成人毛片60女人毛片免费| 欧美精品亚洲一区二区| av播播在线观看一区| 中文字幕免费在线视频6| 99热网站在线观看| 午夜影院在线不卡| 亚洲精品国产成人久久av| 色5月婷婷丁香| 成人特级av手机在线观看| 国产成人一区二区在线| 王馨瑶露胸无遮挡在线观看| 成人毛片60女人毛片免费| 麻豆乱淫一区二区| 日韩不卡一区二区三区视频在线| 免费少妇av软件| 国产视频首页在线观看| 国产精品一区二区三区四区免费观看| 一本大道久久a久久精品| 天天躁夜夜躁狠狠久久av| 欧美3d第一页| 久久久久久伊人网av| 日本欧美视频一区| 国产视频首页在线观看| 女人久久www免费人成看片| 一本大道久久a久久精品| 日韩av不卡免费在线播放| 亚洲精品中文字幕在线视频 | 欧美成人精品欧美一级黄| 国产精品秋霞免费鲁丝片| 久久国产精品男人的天堂亚洲 | 国产男女内射视频| 十八禁网站网址无遮挡 | 亚洲激情五月婷婷啪啪| 亚洲国产欧美日韩在线播放 | 蜜桃在线观看..| 嫩草影院新地址| 插逼视频在线观看| 亚洲精品成人av观看孕妇| 成人黄色视频免费在线看| 黑人巨大精品欧美一区二区蜜桃 | av免费在线看不卡| 午夜免费男女啪啪视频观看| 亚洲色图综合在线观看| 高清午夜精品一区二区三区| 最近2019中文字幕mv第一页| 最新中文字幕久久久久| 免费人成在线观看视频色| 成人漫画全彩无遮挡| 亚洲成色77777| 国产精品久久久久久精品电影小说| 国产亚洲5aaaaa淫片| 黑人巨大精品欧美一区二区蜜桃 | 99久久中文字幕三级久久日本| 日韩欧美一区视频在线观看 | 欧美日韩一区二区视频在线观看视频在线| 乱系列少妇在线播放| 精华霜和精华液先用哪个| 国产高清三级在线| 亚洲av电影在线观看一区二区三区| 岛国毛片在线播放| 国产淫片久久久久久久久| 自拍偷自拍亚洲精品老妇| 亚洲国产精品国产精品| 国产亚洲午夜精品一区二区久久| 黄色配什么色好看| 久久久久精品性色| 少妇丰满av| 美女中出高潮动态图| 精品少妇久久久久久888优播| 夜夜看夜夜爽夜夜摸| 亚洲欧美中文字幕日韩二区| 国产免费一级a男人的天堂| 日本欧美国产在线视频| 人妻夜夜爽99麻豆av| 精品久久国产蜜桃| 国产精品久久久久成人av| 日本黄色日本黄色录像| 我要看日韩黄色一级片| 中国美白少妇内射xxxbb| 男女国产视频网站| kizo精华| 在线观看美女被高潮喷水网站| 亚洲久久久国产精品| 久久青草综合色| 久久鲁丝午夜福利片| 免费观看无遮挡的男女| 国产成人精品福利久久| 国产成人a∨麻豆精品| 亚洲av不卡在线观看| 观看av在线不卡| 亚洲人成网站在线播| 久久精品国产自在天天线| 成年av动漫网址| 国产一区二区在线观看av| 精品人妻一区二区三区麻豆| 七月丁香在线播放| tube8黄色片| 桃花免费在线播放| 国产色婷婷99| 国产高清国产精品国产三级| 色网站视频免费| 99热这里只有是精品在线观看| 女人精品久久久久毛片| 国产伦在线观看视频一区| 2021少妇久久久久久久久久久| 深夜a级毛片| 夜夜爽夜夜爽视频| 日日摸夜夜添夜夜爱| 国内少妇人妻偷人精品xxx网站| 内地一区二区视频在线| 日韩强制内射视频| 99精国产麻豆久久婷婷| 色视频www国产| 黑人高潮一二区| 午夜福利,免费看| 国内精品宾馆在线| 国产精品无大码| 大又大粗又爽又黄少妇毛片口| 中文字幕av电影在线播放| a级毛片在线看网站| 国产在线一区二区三区精| 中国国产av一级| 免费观看av网站的网址| 香蕉精品网在线| 啦啦啦在线观看免费高清www| 免费看光身美女| 国产精品一区www在线观看| 一区二区av电影网| 日日摸夜夜添夜夜添av毛片| 最近手机中文字幕大全| 2022亚洲国产成人精品| 国产一区有黄有色的免费视频| 嫩草影院新地址| 伊人亚洲综合成人网| 亚洲人成网站在线播| 91久久精品国产一区二区三区| 插逼视频在线观看| 国产精品久久久久久久久免| √禁漫天堂资源中文www| 色网站视频免费| 国产精品久久久久久精品古装| 精品午夜福利在线看| 伦理电影大哥的女人| 少妇熟女欧美另类| 日韩大片免费观看网站| 人妻制服诱惑在线中文字幕| 少妇 在线观看| 各种免费的搞黄视频| 黄色一级大片看看| 一级黄片播放器| 国产成人免费观看mmmm| 国产在线视频一区二区| 亚洲人与动物交配视频| 国产精品国产三级国产av玫瑰| 亚洲国产日韩一区二区| 午夜激情福利司机影院| 99久久中文字幕三级久久日本| 日本黄色日本黄色录像| 久久久久国产精品人妻一区二区| 丰满人妻一区二区三区视频av| 国产欧美亚洲国产| 99热全是精品| 自拍欧美九色日韩亚洲蝌蚪91 | 国产高清有码在线观看视频| 亚洲激情五月婷婷啪啪| 国产高清三级在线| 黄色毛片三级朝国网站 | 久久久久久久久久久丰满| 成人18禁高潮啪啪吃奶动态图 | 久久国产乱子免费精品| 久久久精品免费免费高清| 国模一区二区三区四区视频| 亚洲精品日韩av片在线观看| 欧美变态另类bdsm刘玥| 欧美 亚洲 国产 日韩一| 人人妻人人澡人人看| 亚洲,欧美,日韩|